Drug Trial Radar · NCT07055087
Prevent Cognitive Decline in GBA-associated Parkinson's Disease
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Oct 2026
Primary completion
Dec 2030
Study completion May 2031
Sponsor
- Lead sponsor
- University Hospital TuebingenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 35 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a proof-of-concept trial to investigate the efficacy of prasinezumab to slow or prevent cognitive decline in people with Parkinson's disease carrying a severe mutation in the GBA (glucocerebrosidase) gene. The duration of the intervention per patient will be 104 weeks with monthly infusions. The investigators plan to enroll 120 participants (60 participants per treatment arm). This study will be conducted across Europe in the following countries: France, Germany, Italy, Luxembourg, Spain, Sweden, UK.
Conditions
- Parkinson's Disease
Interventions
PrasinezumabDrug
Prasinezumab 1500 mg monthly infusion
Sodium ChlorideDrug
Saline infusion (0,9 % sodium chloride) monthly infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Parkinson's Disease Cognitive Composite Score (PDCCS)Time frame: week 104
Locations
11 sites in 7 countries. Site status is shown where the registry gives one.
Sorbonne University, Pitié-Salpêtrière Hospital
Paris, France · Not yet recruiting
University Hospital C. G. Carus TU Dresden
Dresden, Germany · Not yet recruiting
University Hospital Tubingen
Tübingen, Germany · Recruiting
University of Brescia and ASST Spedali Civili of Brescia
Brescia, Italy · Not yet recruiting
Fondazione IRCCS Ca' Granda Policlinico Hospital
Milan, Italy · Not yet recruiting
University of Pavia
Pavia, Italy · Not yet recruiting
University of Luxemburg
Luxembourg, Luxembourg · Not yet recruiting
Hospital Universitario HM Puerta del Sur, Madrid
Madrid, Spain · Not yet recruiting
Hospital Universitario Virgen del Rocío, Sevilla
Seville, Spain · Not yet recruiting
Karolinska University of Stockholm
Stockholm, Sweden · Not yet recruiting
University of Oxford
Oxford, United Kingdom · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.